Showing 126–150 of 200 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
World Health Organization
World Health Organization
World Health Organization
World Health Organization
Mussi-Pinhata, M. M., Goncalves, A. L., Foss, N. T.
World Health Organization
World Health Organization
World Health Organization
World Health Organization
Tolderlund, Knud, Bunch-Christensen, Kirsten, Waaler, Hans
Kanipe C, Boggiatto PM, Putz EJ, Palmer MV
[This corrects the article DOI: 10.3389/fmicb.2022.1048648.].
Milstien, J. B., Gibson, J. J.
World Health Organization
Červenka, J., Tlučková, I.
Obayashi, Yoji, Sawada, Tetsuji, Kuchiki, Gorosaku, Cho, Chujo, Kawasaki, Jiro, et al.
World Health Organization
Lin, H. T.
…lipid antigen for incorporation into multicomponent subunit vaccines. In this study, we utilized the enhanced stability of bicontinuous nanospheres (BCN) to efficiently encapsulate MA for in vivo delivery to MA-specific T cells, both alone and in combination with an immunodominan…
…lipid antigen for incorporation into multicomponent subunit vaccines. In this study, we utilized the enhanced stability of bicontinuous nanospheres (BCN) to efficiently encapsulate MA for in vivo delivery to MA-specific T cells, both alone and in combination with an immunodominan…
François Nosten, Professor
…pant will receive single or double doses of one of COVID-19 vaccines (Pfizer-BioNTech COVID-19 vaccine, AstraZeneca vaccine or Janssen Ad26.COV2.S COVID-19 vaccine) in the deltoid muscle of the non-dominant arm. Study Duration approximately 1 year. The main focus of this study is…
Mark F. Cotton, Helena Rabie
…. WHO established criteria for introducing new tuberculosis vaccines in 2018, supporting efficacy of at least 50% in adults and adolescents, although acknowledging that a slightly less efficacious vaccine could be beneficial in this population. For infants, a vaccine should be ei…
Helen McShane
…tify a potential correlate of protection. Future candidate vaccines can then be assessed against their capacity to induce such an immune response. Potential risks to human subjects: The general risks to participants in this human pilot study are associated with phlebotomy, vac…
Jinxiang Xi, Xiuhua April
…irus disease 2019 (COVID-19). Up to date, approved COVID-19 vaccines and boosters are all administered intramuscularly. Interests in developing mucosal vaccination have been arising again during this pandemic for its convenience and painless characteristics.2 COVID-19 is known as…
Mangalakumari Jeyanathan, Dominik Fritz, Sam Afkhami, Emilio Aguirre, Karen Howie, et al.
Summary Background Adenoviral (Ad)-vectored vaccines are typically administered via intramuscular injection to humans, but this route of delivery is unable to induce respiratory mucosal immunity which requires respiratory mucosal route of vaccination. However, inhaled aerosol del…
Allison Portnoy, Rebecca A. Clark, Matthew Quaife, Chathika K. Weerasuriya, Christinah Mukandavire, et al.
…liminating it has proven challenging. Safe and effective TB vaccines that can rapidly reduce disease burden are essential for achieving TB elimination. We assessed future costs, cost-savings, and cost-effectiveness of introducing novel TB vaccines in low- and middle-income countr…